Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 5.

Journal Article

Frost, Nikolaj ORCID: 0000-0001-7452-7129, Christopoulos, Petros ORCID: 0000-0002-7966-8980, Kauffmann-Guerrero, Diego, Stratmann, Jan, Riedel, Richard, Schaefer, Monica, Alt, Jurgen, Gutz, Sylvia, Christoph, Daniel C., Laack, Eckart, Faehling, Martin, Fischer, Richard, Fenchel, Klaus, Haen, Sebastian, Heukamp, Lukas, Schulz, Christian and Griesinger, Frank (2021). Lorlatinib in pretreated ALK- or ROS1-positive lung cancer and impact of TP53 co-mutations: results from the German early access program. Ther. Adv. Med. Oncol., 13. LONDON: SAGE PUBLICATIONS LTD. ISSN 1758-8359

Mairinger, Fabian D., Walter, Robert F. H., Ting, Saskia ORCID: 0000-0003-1415-7714, Vollbrecht, Claudia ORCID: 0000-0002-0861-001X, Kollmeier, Jens ORCID: 0000-0002-8048-3895, Griff, Sergei, Hager, Thomas, Mairinger, Thomas, Christoph, Daniel C., Theegarten, Dirk, Schmid, Kurt Werner and Wohlschlaeger, Jeremias (2014). Mdm2 protein expression is strongly associated with survival in malignant pleural mesothelioma. Future Oncol., 10 (6). S. 995 - 1006. LONDON: FUTURE MEDICINE LTD. ISSN 1744-8301

Mairinger, Fabian D., Walter, Robert F. H., Werner, Robert, Christoph, Daniel C., Ting, Saskia ORCID: 0000-0003-1415-7714, Vollbrecht, Claudia ORCID: 0000-0002-0861-001X, Zarogoulidis, Konstantinos, Huang, Haidong, Li, Qiang, Schmid, Kurt W., Wohlschlaeger, Jeremias and Zarogoulidis, Paul (2014). Activation of Angiogenesis Differs Strongly Between Pulmonary Carcinoids and Neuroendocrine Carinomas and Is Crucial for Carcinoid Tumourgenesis. J. Cancer, 5 (6). S. 465 - 472. LAKE HAVEN: IVYSPRING INT PUBL. ISSN 1837-9664

Metzenmacher, Martin ORCID: 0000-0001-5395-9010, Rizzo, Filippo, Kambartel, Kato, Panse, Jens, Schaufler, Diana, Scheffler, Matthias ORCID: 0000-0002-9031-1368, Azeh, Ivo, Hoiczyk, Mathias, Turki, Amin T., Atz, Judith, Buchner, Hannes, Hoffmann, Christopher and Christoph, Daniel C. (2021). Real-world efficacy of docetaxel plus nintedanib after chemo-immunotherapy failure in advanced pulmonary adenocarcinoma. Future Oncol., 17 (30). S. 3965 - 3977. LONDON: FUTURE MEDICINE LTD. ISSN 1744-8301

Stratmann, Jan A., Michels, Sebastian, Hornetz, Sofia, Christoph, Daniel C., Sackmann, Sandra, Spengler, Werner, Bischoff, Helge, Schaefer, Monica, Alt, Juergen, Mueller, Annette, Laack, Eckart, Kimmich, Martin, Griesinger, Frank and Sebastian, Martin (2018). Efficacy and safety analysis of the German expanded access program of osimertinib in patients with advanced, T790M-positive non-small cell lung cancer. J. Cancer Res. Clin. Oncol., 144 (12). S. 2457 - 2464. NEW YORK: SPRINGER. ISSN 1432-1335

This list was generated on Wed Apr 24 00:15:13 2024 CEST.